Dear Reader,
Greetings from Germany, where the sun finally shines! I am happy to share with you the latest edition of "Profil World" - our newsletter packed with information about clinical research in diabetes and obesity.
|
EMA, Brexit and new updates about EU Directive 536/2014
|
 |
The European Medicines Agency (EMA) is preparing itself for the Brexit. There is a whole plan in motion, including its headquarters' relocation and new changes to the timeline of the European Directive 536/2014. Read more.
|
|
|
|
First in Human clinical trials challenges and new guideline on risk mitigation
|
 |
Continuing our online seminar series, our experts presented the online seminar "First in Human Trials: Scientific Considerations". If you missed it, you can still watch our recorded online seminar.
|
|
|
|
Is non-invasive glucose monitoring a possibility?
|
 |
Our expert in medical devices, Dr. Eric Zijlstra, recently wrote a thought provoking blog post about the challenges for the development of a smart contact lens to monitor glucose level. Read more.
|
|
|
|
Metabolic ward at Profil
|
 |
Standardization of nutritional plans is a crucial aspect while performing many clinical studies investigating metabolic disorders. Learn more about Profil's capabilities and dedicated medical metabolic ward.
|
|
|
Meet us at EASD
|
 |
Are you planning to join EASD in September? We would love to have a lively discussion and tell you more about Profil's work! Let us know, so we can schedule a meeting. |
|
|
|
|
We wish you a good week and look forward to the next "Profil World",
Tatiana Dicenzo - Scientific Communication Manager, Profil
|
|
